Tricyclic anti-depressants such as
Elavil, selective serotonin reuptake inhibitors (SSRIs) such as
Prozac or
Lexapro, and especially serotonin and norepinephrine reuptake inhibitors (SNRIs) such as
Effexor or
Cymbalta, which are dual-acting antidepressants that can increase both serotonin and norepinephrine, have proven capable of decreasing pain while treating both depression and chronic pain. Because pain can induce depression and vice versa, these new dual-acting agents can provide physicians with safe and…
Follow the story of Tracey who's insurer would not pay for her
Celebrex prescription. Read on...
Who's the Doctor?